AcrySof IQ VIVITY
Device Ophthalmology
PDI 00380652424837
General payments
$1,604,142
Research payments
$741,267
Through program year 2025, $1,604,142 in general payments and $741,267 in research payments were reported against AcrySof IQ VIVITY (Ophthalmology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $370,250 | 259 |
| 2025 | Research | $58,712 | 3 |
| 2024 | General | $522,814 | 469 |
| 2024 | Research | $126,068 | 4 |
| 2023 | General | $342,121 | 383 |
| 2023 | Research | $111,347 | 5 |
| 2022 | General | $368,531 | 2,100 |
| 2022 | Research | $445,140 | 13 |
| 2021 | General | $426 | 4 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 21 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,215 general · 25 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.